EE200300255A - Asitromütsiin monohüdraadina, selle valmistamismeetod ja selle kasutamine ravimkoostises - Google Patents

Asitromütsiin monohüdraadina, selle valmistamismeetod ja selle kasutamine ravimkoostises

Info

Publication number
EE200300255A
EE200300255A EEP200300255A EEP200300255A EE200300255A EE 200300255 A EE200300255 A EE 200300255A EE P200300255 A EEP200300255 A EE P200300255A EE P200300255 A EEP200300255 A EE P200300255A EE 200300255 A EE200300255 A EE 200300255A
Authority
EE
Estonia
Prior art keywords
azithromycin
monohydrate
preparation
pharmaceutical compositions
pharmaceutical
Prior art date
Application number
EEP200300255A
Other languages
English (en)
Inventor
Centellas Victor
Diago Jos�
Garcia Rafael
Ludescher Johannes
Original Assignee
Biochemie S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0031355A external-priority patent/GB0031355D0/en
Application filed by Biochemie S.A. filed Critical Biochemie S.A.
Publication of EE200300255A publication Critical patent/EE200300255A/et
Publication of EE05200B1 publication Critical patent/EE05200B1/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
EEP200300255A 2000-11-27 2001-11-26 Asitromtsiin monohdraadina, selle valmistamismeetod ja selle kasutamine ravimkoostises EE05200B1 (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25311900P 2000-11-27 2000-11-27
GB0031355A GB0031355D0 (en) 2000-12-21 2000-12-21 Organic compounds
PCT/EP2001/013760 WO2002042315A2 (en) 2000-11-27 2001-11-26 Macrolide solvates

Publications (2)

Publication Number Publication Date
EE200300255A true EE200300255A (et) 2003-08-15
EE05200B1 EE05200B1 (et) 2009-08-17

Family

ID=26245472

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300255A EE05200B1 (et) 2000-11-27 2001-11-26 Asitromtsiin monohdraadina, selle valmistamismeetod ja selle kasutamine ravimkoostises

Country Status (15)

Country Link
US (1) US6949519B2 (et)
EP (1) EP1339730A2 (et)
JP (1) JP2004519430A (et)
KR (1) KR100815163B1 (et)
AU (1) AU2002221895A1 (et)
BG (1) BG66200B1 (et)
CA (1) CA2429639C (et)
CZ (1) CZ303343B6 (et)
EE (1) EE05200B1 (et)
HR (1) HRP20030430B1 (et)
HU (1) HU229488B1 (et)
NO (1) NO324951B1 (et)
PL (1) PL207076B1 (et)
SK (1) SK287814B6 (et)
WO (1) WO2002042315A2 (et)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20020231A2 (en) * 2002-03-18 2003-12-31 Pliva D D ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A
US6861413B2 (en) 2001-05-22 2005-03-01 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
JP2004530703A (ja) 2001-05-22 2004-10-07 ファイザー・プロダクツ・インク 結晶形アジスロマイシン
GB0214277D0 (en) * 2002-06-20 2002-07-31 Biochemie Gmbh Organic compounds
US6855813B2 (en) 2002-07-19 2005-02-15 Alembic Limited Process for the preparation of azithromycin monohydrate
HRP20020614A2 (en) 2002-07-22 2004-06-30 PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a
GB0224197D0 (en) * 2002-10-17 2002-11-27 Biochemie Gmbh Organic compounds
CA2520192A1 (en) * 2003-03-25 2004-10-14 Teva Pharmaceutical Industries Ltd. Degradation products of azithromycin, and methods for their identification
US20050101547A1 (en) * 2003-11-06 2005-05-12 Sadatrezaei Mohsen Stabilized azithromycin composition
US7943585B2 (en) 2003-12-22 2011-05-17 Sandoz, Inc. Extended release antibiotic composition
US7384921B2 (en) 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US7683162B2 (en) * 2004-08-30 2010-03-23 Taro Pharmaceutical Industries Limited Process of preparing a crystalline azithromycin monohydrate
JP4471941B2 (ja) * 2005-03-10 2010-06-02 山一電機株式会社 半導体装置用ソケット
US20090318375A1 (en) * 2005-06-08 2009-12-24 Hanmi Pharm Co., Ltd Crystalline Azithromycin L-Malate Monohydrate and Pharmaceutical Composition Containing Same
MX2011009548A (es) 2009-03-13 2011-12-14 Da Volterra Composiciones y metodos para la eliminacion de bacterias gram-negativas.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI8110592A8 (en) 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
RU2066324C1 (ru) * 1987-07-09 1996-09-10 Пфайзер Инк. Кристаллический дигидрат азитромицина и способ его получения
WO1989002271A1 (en) * 1987-09-10 1989-03-23 Pfizer Azithromycin and derivatives as antiprotozoal agents
PT102006B (pt) 1997-05-19 2000-06-30 Hovione Sociedade Quimica S A Novo processo de preparacao de azitromicina
PT102130A (pt) 1998-03-13 1999-09-30 Hovione Sociedade Quimica S A Processo de preparacao de dihidrato de azitromicina
CA2245398C (en) 1998-08-21 2002-01-29 Apotex Inc. Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
JP2002531409A (ja) * 1998-11-30 2002-09-24 テバ ファーマシューティカル インダストリーズ リミティド アジスロマイシンのエタノール付加物、その製造方法、及びその医薬製剤
DE60029589T2 (de) 1999-06-29 2007-07-19 Sandoz Ag Verfahren zur herstellung von azithromycin
ES2177373B1 (es) 1999-11-26 2003-11-01 Astur Pharma Sa Preparacion de azitromicina en su forma no cristalina

Also Published As

Publication number Publication date
US6949519B2 (en) 2005-09-27
NO20032371D0 (no) 2003-05-26
EP1339730A2 (en) 2003-09-03
KR100815163B1 (ko) 2008-03-19
CA2429639C (en) 2009-07-14
HRP20030430B1 (en) 2011-11-30
PL361276A1 (en) 2004-10-04
BG66200B1 (bg) 2012-01-31
CA2429639A1 (en) 2002-05-30
AU2002221895A1 (en) 2002-06-03
WO2002042315A3 (en) 2002-10-31
WO2002042315A2 (en) 2002-05-30
NO20032371L (no) 2003-07-10
HRP20030430A2 (en) 2005-04-30
EE05200B1 (et) 2009-08-17
PL207076B1 (pl) 2010-10-29
HUP0302099A2 (hu) 2003-10-28
SK6352003A3 (en) 2003-11-04
KR20030055305A (ko) 2003-07-02
US20040053862A1 (en) 2004-03-18
BG107832A (bg) 2004-07-30
HUP0302099A3 (en) 2009-08-28
CZ20031439A3 (cs) 2003-10-15
JP2004519430A (ja) 2004-07-02
CZ303343B6 (cs) 2012-08-08
NO324951B1 (no) 2008-01-14
SK287814B6 (sk) 2011-11-04
HU229488B1 (hu) 2014-01-28

Similar Documents

Publication Publication Date Title
EE200300171A (et) Kristalliline monohüdraat, meetodid selle valmistamiseks ja selle kasutamine farmatseutilise kompositsiooni valmistamiseks
EE200200487A (et) Asetidiini derivaadid, nende valmistamismeetodid ja farmatseutiline kompositsioon
EE200100684A (et) Indalüülasendatud benseenkarboksamiidid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
EE200300255A (et) Asitromütsiin monohüdraadina, selle valmistamismeetod ja selle kasutamine ravimkoostises
EE200300587A (et) Vedel farmatseutiline kompositsioon, selle valmistamise meetod ja kasutamine
HUP0301315A3 (en) Benzothiazole derivatives, process for their preparation, their use and pharmaceutical compositions containing them
EE05214B1 (et) Polool-IFN- β konjugaat, selle valmistamismeetod ja farmatseutiline kompositsioon
HUP0600141A3 (en) Low hygroscopic aripiprazole-anhydrate process for its preparation, pharmaceutical compositions containing it and its use
EE200300369A (et) Atsüülitud indanüülamiinid, nende valmistamismeetod, kasutamine ja farmatseutiline preparaat
EE200300327A (et) Uurea derivaadid, nende valmistamismeetodid, kasutamine ja farmatseutiline kompositsioon
IL156662A0 (en) Oxazolidinone derivatives, process for the preparation thereof and pharmaceutical compositions containing the same
IL151496A0 (en) Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same
EE200300245A (et) Bensotiofeeni derivaadid, nende valmistamise meetod ja kasutamine
HUP0302295A3 (en) Thienodibenzoazulene derivatives, process for their preparation and use thereof
PL394600A1 (pl) Związek winyloazacykloalkanowy, sposób jego wytwarzania i jego zastosowanie oraz kompozycja farmaceutyczna
NO20032614D0 (no) Farmasöytisk sammensetning med forbedret absorbabilitet
EE05175B1 (et) Asendatud bensimidasooli preparaat, meetod selle valmistamiseks ja selle kasutamine meditsiinis
EE04311B1 (et) Asoolid, nende valmistamismeetod, kasutamine ravimina ja farmatseutiline kompositsioon
EE04902B1 (et) Mikrograanul, selle valmistamismeetod ja farmatseutiline preparaat
HK1065708A1 (en) Pharmaceutical composition based on macrolides for topical application in ophthalmology
HK1054033A1 (zh) 4-嘧啶胺衍生物、藥用組合物和相關方法
HUP0401369A3 (en) Pharmaceutical formulation comprising (r)-bicalutamide, process for its preparation and use thereof
HUP0203859A3 (en) Aminomethyl-phenyl-cyclohexanone derivatives, process for their preparation, pharmaceutical compositions containing them and their use
IL154986A0 (en) Triazolo-epothilone derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof
EP1556364A4 (en) ISOTHIAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THESE DERIVATIVES

Legal Events

Date Code Title Description
GB1A Change in the ownership or in the address of the owner
HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20151126